Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America
This clinical trial update reports epidemiological characteristics of gastric, gastroesophageal, and pancreatic cancers in Latin America; th…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Prospective Monocentric Clinical-biological Database [NA]
A prospective monocentric clinical-biological database for pancreatic cancer is currently recruiting. The sponsor is Institut du Cancer de M…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer [NA]
A clinical trial investigating precision imaging for early detection and monitoring of pancreatic cancer is currently recruiting. Sponsored …
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer
A registry study evaluating the NanoKnife Irreversible Electroporation system for Stage III pancreatic cancer, sponsored by Angiodynamics, w…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Percutaneous Holmium Injection in Pancreatic Cancer [NA]
This clinical trial update concerns percutaneous holmium injection for pancreatic cancer. The study is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase I/II trial update for VB15010 tablets in advanced solid tumors; the study is currently recruiting across multiple cancer types.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer [Phase 2]
Phase II study evaluating MR-guided radiotherapy dose escalation for unresectable non-metastatic pancreatic cancer; results have been posted…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
This clinical trial update notes that an early-stage detection study for liver cancer, biliary tract cancer, and pancreatic cancer is curren…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer [Phase 1]
A Phase 1 trial of Biomea Fusion's covalent menin inhibitor BMF-219 in KRAS-driven non-small cell lung cancer, pancreatic cancer, and colore…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic Cancer [Phase 1]
Phase 1 open-label, uncontrolled study evaluating ONO-4578 and ONO-4538 in combination with standard first-line therapies (modified FOLFIRIN…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer [Phase 1, Phase 2]
An ongoing Phase 1/2 trial is evaluating Onvansertib in combination with NALIRIFOX for first-line treatment of advanced pancreatic cancer; t…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial ACCENT is evaluating AMP945 in combination with nab-paclitaxel and gemcitabine for pancreatic cancer in Phase 1/2; the study …
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer
This clinical trial registry entry notes that the study evaluating the optimal duration of neoadjuvant therapy for resectable pancreatic can…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC) [Phase 3]
Phase 3 trial ADJUPANC comparing adjuvant chemoradiotherapy versus chemotherapy for pancreatic cancer is currently recruiting, sponsored by …
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal Adenocarcinoma
This clinical trial update from Charles University investigates whether secretin-stimulated pancreatic secretion affects ctDNA expression in…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating GVAX Pancreas Vaccine with cyclophosphamide in combination with nivolumab and SBRT for borderline resectable panc…
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
A clinical trial network in Ontario (MOHCCN-O) is currently recruiting across multiple cancer indications, including breast, colorectal, pan…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial results have been posted for a combination of CRS-207, pembrolizumab, ipilimumab, and tadalafil in metastatic pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Study of a New Technique for Imaging Pancreatic Cancer [Phase 1]
Phase 1 study evaluating a novel imaging technique for pancreatic cancer has completed, including tumors expressing the CA19-9 biomarker.
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer [NA]
A clinical trial is recruiting to analyze gut microbiota in adults undergoing duodencephalopancreasectomy for pancreatic cancer.
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Tumor Registry Pancreatic Cancer
The Tumor Registry pancreatic cancer clinical trial has completed. The provided snippet does not include trial results.
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer [Phase 2]
A Phase 2 trial compares gemcitabine to a reduced-dose combination chemotherapy in fragile patients with non-resectable pancreatic cancer; t…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies
Viome's completed clinical trial update reports analyses of the intestinal microbiome, oral microbiome, and whole-blood transcriptome across…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001) [Phase 1]
Phase 1 study of mRNA-5671/V941 as monotherapy and in combination with pembrolizumab (V941-001) was terminated, with results posted on 2025-…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating a triplet regimen of liposomal irinotecan, S-1, and oxaliplatin in advanced pancreatic cancer (pancre…